Real-world findings indicate G/P shows safety and efficacy in treating chronic HCV in children, suggesting further data is needed.
Our real-world findings suggest that G/P is a potentially safe and efficacious treatment option for children and adolescents with chronic HCV infection. Further data on patients with compensated cirrhosis and long-term post-SVR outcomes would be valuable.
No takes yet. Share an insight, caveat, or question.
Mizuochi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: